In July 2022, the EMA adopted a positive opinion, recommending the granting of marketing authorization for tirzepatide as a therapeutic agent for T2D (56)
Ongoing Innovation: Companies should continue to innovate and seek new indications and formulations (such as combination therapies) to broaden the scope of GLP-1 receptor agonists
Journal of Hepatology 53 , 10851094, doi: 10.1016/j.jhep.2010.05.028 (2010)
By 2030, it is expected that this number could grow to more than 1 billion people, with over 120 million of those in the U.S
In a murine study, it was shown that the administration of vitamins C and E caused decreases in ragweed extract-induced ROS levels and is associated with lower airway allergic inflammation [82]
Our BioEnergies imbedded in the tablets apply specific frequencies and amplitudes on biological oscillators